Fig. 11
From: HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma
The HSF1 inhibitor KRIBB-11 and the apoptosis inducer ABT-263 reduce the viability of iCCA organoids. A, B Effect of ABT-263, KRIBB-11, and their combination on the viability of iCCA organoids, treated for 10 days in the specific medium of the hepatic organoid. Experiments were repeated three times in triplicate. ***P < 0.001, as calculated with a One-way ANOVA test